Sunil Agarwal Sana Biotechnology, Inc. (SANA) insider trading activity

SANA Quotes by TradingView

Sunil Agarwal is EVP, Head of Development & CMO of Sana Biotechnology, Inc.. Currently has a direct ownership of 1.55 Million shares of SANA, which is worth approximately $5.43 Million. The most recent transaction as insider was on Sep 16, 2021, when has been sold 1,627 shares (Common Stock) at a price of $26.0 per share, resulting in proceeds of $42,302. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.55M
0% 3M change
0% 12M change
Total Value Held $5.43 Million

SUNIL AGARWAL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2021
SELL
Open market or private sale
$42,302 $26.0 p/Share
1,627 Reduced 0.1%
1,550,000 Common Stock
Sep 15 2021
SELL
Open market or private sale
$1,521,784 $26.07 p/Share
58,373 Reduced 3.63%
1,551,627 Common Stock

Also insider at

ARVN
ARVINAS, INC. Healthcare
Director
CALA
Calithera Biosciences, Inc. Healthcare
Director
ATXS
Astria Therapeutics, Inc. Healthcare
Director
MYOK
MyoKardia Inc
Director
SA

Sunil Agarwal

EVP, Head of Development & CMO
Seattle, WA

Track Institutional and Insider Activities on SANA

Follow Sana Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SANA shares.

Notify only if

Insider Trading

Get notified when an Sana Biotechnology, Inc. insider buys or sells SANA shares.

Notify only if

News

Receive news related to Sana Biotechnology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SANA